Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, May 31, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Thu, May 30, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Michael Ha Initiated (asth) at Buy and Held Target at $54 on, May 30th, 2024
Michael Ha of Baird, Initiated "Astrana Health, Inc." (ASTH) at Buy and Held Target at $54 on, May 30th, 2024.
Michael has made no other calls on ASTH in the last 4 months.
There are 2 other peers that have a rating on ASTH. Out of the 2 peers that are also analyzing ASTH, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jailendra Singh of "Truist Securities" Maintained at Hold with Increased Target to $44 on, Friday, March 1st, 2024
This is the rating of the analyst that currently disagrees with Michael
- Craig Jones of "Stifel" Maintained at Strong Buy with Decreased Target to $45 on, Wednesday, May 8th, 2024
